| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc. (RVMD) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. RVMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $387.81M | - | |
| Other | 278.6K | $46.19M | - | |
| Other | 232.5K | $38.55M | - | |
| COO | 119.9K | $19.88M | - | |
| ? | 96.6K | $16.01M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2021 | Goldsmith Mark A52 | See Remarks | Sale+OE | 15,000 | $55.00 | $825,000.00 | -95.3% | |
| Feb 4, 2021 | Weber Barbara59 | Director | Sale+OE | 5,000 | $50.35 | $251,766.97 | -52.5% | |
| Feb 2, 2021 | Goldsmith Mark A52 | See Remarks | Sale+OE | 5,000 | $45.42 | $227,101.24 | -68.6% | |
| Feb 2, 2021 | Weber Barbara59 | Director | Sale+OE | 5,336 | $45.00 | $240,120.00 | -74.7% | |
| Dec 30, 2020 | Weber Barbara59 | Director | Sale+OE | 5,336 | $40.95 | $218,529.92 | -58.9% | |
| Nov 16, 2020 | Column Group Iii, LP | 10% Owner | Sell | 2,027,156 | $36.40 | $73,788,478.40 | -30.7% | |
| Nov 16, 2020 | Svennilson Peter83 | Director, 10% Owner | Sell | 2,027,156 | $36.40 | $73,788,478.40 | -30.7% | |
| Oct 15, 2020 | Anderson Elizabeth M | Director | Sell | 5,000 | $45.00 | $225,000.00 | -7.8% | |
| Oct 13, 2020 | Anders Jack47 | See Remarks | Sale+OE | 10,000 | $44.00 | $440,000.00 | -100% | |
| Oct 6, 2020 | Anders Jack47 | See Remarks | Sale+OE | 10,000 | $40.00 | $400,000.00 | -100% |